Ratios Revealed: Decoding RxSight Inc (RXST)’s Financial Health

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

The closing price of RxSight Inc (NASDAQ: RXST) was $8.22 for the day, down -1.08% from the previous closing price of $8.31. In other words, the price has decreased by -$1.08 from its previous closing price. On the day, 0.99 million shares were traded. RXST stock price reached its highest trading level at $8.34 during the session, while it also had its lowest trading level at $8.03.

Ratios:

Our analysis of RXST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.70 and its Current Ratio is at 13.93. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.

On July 10, 2025, Jefferies Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $9.

Wells Fargo Downgraded its Overweight to Equal Weight on July 09, 2025, while the target price for the stock was maintained at $9.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 12 ’25 when Fountain Tamara sold 7,000 shares for $25.71 per share. The transaction valued at 180,002 led to the insider holds 24,793 shares of the business.

TAMARA R FOUNTAIN bought 7,000 shares of RXST for $180,002 on Mar 12 ’25. On Jan 22 ’25, another insider, Maniar Shweta, who serves as the Director of the company, sold 3,519 shares for $30.87 each. As a result, the insider received 108,618 and left with 7,383 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXST now has a Market Capitalization of 336329536 and an Enterprise Value of 120553216. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.29 while its Price-to-Book (P/B) ratio in mrq is 1.21. Its current Enterprise Value per Revenue stands at 0.82 whereas that against EBITDA is -3.066.

Stock Price History:

The Beta on a monthly basis for RXST is 1.16, which has changed by -0.8442887 over the last 52 weeks, in comparison to a change of 0.16461086 over the same period for the S&P500. Over the past 52 weeks, RXST has reached a high of $58.23, while it has fallen to a 52-week low of $6.32. The 50-Day Moving Average of the stock is -21.93%, while the 200-Day Moving Average is calculated to be -67.02%.

Shares Statistics:

RXST traded an average of 1.29M shares per day over the past three months and 1235660 shares per day over the past ten days. A total of 40.91M shares are outstanding, with a floating share count of 37.98M. Insiders hold about 7.17% of the company’s shares, while institutions hold 97.23% stake in the company. Shares short for RXST as of 1753920000 were 6225276 with a Short Ratio of 4.83, compared to 1751241600 on 5790650. Therefore, it implies a Short% of Shares Outstanding of 6225276 and a Short% of Float of 15.97.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.